The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R01 | Nasal preparations | |
| 3 | R01A | Decongestants and other nasal preparations for topical use | |
| 4 | R01AX | Other nasal preparations | |
| 5 | R01AX06 | Mupirocin |
| Active Ingredient | Description | |
|---|---|---|
| Mupirocin |
Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| BACTROBAN 2% Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| BACTROBAN Nasal ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MURIPOCIN 2% w/w Ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
